ARUP Senior Pharmacy Consultant Ryan Nelson, PharmD, is the author of several papers aimed at helping oncologists use pharmacogenomic testing to guide treatment. He also will discuss the topic during a May 11, 2021, Patient-centered Laboratory Utilization Guidance Services/Medical Training Solutions (PLUGS/MTS) webinar.
ARUP Laboratories Senior Pharmacy Consultant Ryan Nelson, PharmD, is on a quest to share how underused pharmacogenomic testing can help identify and enable guideline-supported therapies.
ARUP Laboratories announced today that the Food and Drug Administration (FDA) has filed ARUP’s premarket approval application (PMA) for an AAV5 total antibody assay.
Pharmacogenetics (PGx) is an area of testing that assesses the genes that affect the body’s response to medications.
Rheumatoid arthritis (RA) is an autoimmune disease, more specifically a noninfectious inflammatory disease. Inflammation results from the overproduction of several proteins in the body.
Adverse drug reactions cause more than 700,000 ER visits each year, with some 120,000 patients needing to be hospitalized for further treatment, according to the CDC.